IMIDAZOLINE RECEPTOR AGONISTS: DO WE KNOW EVERYTHING ABOUT THEIR CAPABILITIES?
<p>The role of selective I1 imidazoline receptor agonists and moxonidine in particular , in modern antihypertensive therapy is discussed. Moxonidine advantages, namely positive effects on insulin resistance, endothelial dysfunction, lipid profile, and plasma fibrinolytic activity are considere...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2015-12-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | http://www.rpcardio.ru/jour/article/view/564 |
| _version_ | 1797757906138955776 |
|---|---|
| author | D. V. Nebieridze T. V. Kamyshova |
| author_facet | D. V. Nebieridze T. V. Kamyshova |
| author_sort | D. V. Nebieridze |
| collection | DOAJ |
| description | <p>The role of selective I1 imidazoline receptor agonists and moxonidine in particular , in modern antihypertensive therapy is discussed. Moxonidine advantages, namely positive effects on insulin resistance, endothelial dysfunction, lipid profile, and plasma fibrinolytic activity are considered.</p> |
| first_indexed | 2024-03-12T18:22:18Z |
| format | Article |
| id | doaj.art-9d696ab9ff194c0d818e238569ce8497 |
| institution | Directory Open Access Journal |
| issn | 1819-6446 2225-3653 |
| language | English |
| last_indexed | 2024-03-12T18:22:18Z |
| publishDate | 2015-12-01 |
| publisher | Столичная издательская компания |
| record_format | Article |
| series | Рациональная фармакотерапия в кардиологии |
| spelling | doaj.art-9d696ab9ff194c0d818e238569ce84972023-08-02T08:49:47ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532015-12-018223323610.1234/1819-6446-2012-2-233-236564IMIDAZOLINE RECEPTOR AGONISTS: DO WE KNOW EVERYTHING ABOUT THEIR CAPABILITIES?D. V. Nebieridze0T. V. Kamyshova1Государственный научно-исследовательский центр профилактической медициныГосударственный научно-исследовательский центр профилактической медицины<p>The role of selective I1 imidazoline receptor agonists and moxonidine in particular , in modern antihypertensive therapy is discussed. Moxonidine advantages, namely positive effects on insulin resistance, endothelial dysfunction, lipid profile, and plasma fibrinolytic activity are considered.</p>http://www.rpcardio.ru/jour/article/view/564артериальная гипертонияагонисты имидазолиновых рецепторовмоксонидин |
| spellingShingle | D. V. Nebieridze T. V. Kamyshova IMIDAZOLINE RECEPTOR AGONISTS: DO WE KNOW EVERYTHING ABOUT THEIR CAPABILITIES? Рациональная фармакотерапия в кардиологии артериальная гипертония агонисты имидазолиновых рецепторов моксонидин |
| title | IMIDAZOLINE RECEPTOR AGONISTS: DO WE KNOW EVERYTHING ABOUT THEIR CAPABILITIES? |
| title_full | IMIDAZOLINE RECEPTOR AGONISTS: DO WE KNOW EVERYTHING ABOUT THEIR CAPABILITIES? |
| title_fullStr | IMIDAZOLINE RECEPTOR AGONISTS: DO WE KNOW EVERYTHING ABOUT THEIR CAPABILITIES? |
| title_full_unstemmed | IMIDAZOLINE RECEPTOR AGONISTS: DO WE KNOW EVERYTHING ABOUT THEIR CAPABILITIES? |
| title_short | IMIDAZOLINE RECEPTOR AGONISTS: DO WE KNOW EVERYTHING ABOUT THEIR CAPABILITIES? |
| title_sort | imidazoline receptor agonists do we know everything about their capabilities |
| topic | артериальная гипертония агонисты имидазолиновых рецепторов моксонидин |
| url | http://www.rpcardio.ru/jour/article/view/564 |
| work_keys_str_mv | AT dvnebieridze imidazolinereceptoragonistsdoweknoweverythingabouttheircapabilities AT tvkamyshova imidazolinereceptoragonistsdoweknoweverythingabouttheircapabilities |